Alpha DNA Investment Management’s Utz Brands UTZ Stock Holding History

Alpha DNA Investment Management’s Portfolio UTZ Stock Details UTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-132	Closed	-$3K	–	631
2021 Q1	$3K	Buy	+132	New	+$3.2K	﹤0.01%	521

Other funds holding UTZ

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Alpha DNA Investment Management's UTZ Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Utz Brands (UTZ) in Q2 2021, closing a stake of 132 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in UTZ in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 154 funds tracked by Wall St. Rank hold UTZ as of Q2 2021.

Alpha DNA Investment Management reported no remaining Utz Brands position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 132 Utz Brands shares in Q2 2021, an estimated $3K.
Alpha DNA Investment Management first reported a position in Utz Brands in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Utz Brands position peaked at $3K in Q1 2021.
154 funds tracked by Wall St. Rank held Utz Brands as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.